PQQ for Mitochondrial Health: How It Compares to Urolithin A’s Evidence Base

As an Amazon Associate, sci-supplements.com earns from qualifying purchases. Links in this article may be affiliate links.

PQQ (pyrroloquinoline quinone) is frequently paired with our urolithin A and NMN content in “mitochondrial support” stacks. It has real, interesting biology behind it – and a smaller, earlier-stage human evidence base than the marketing pace suggests.

The mechanism

PQQ is a redox cofactor found in trace amounts in certain foods. In preclinical research, it has been shown to stimulate mitochondrial biogenesis (the creation of new mitochondria) through activation of the PGC-1alpha pathway, and animal studies show it improves mitochondrial efficiency at low physiological doses. Researchers have proposed PQQ as a candidate “longevity vitamin” based on this mechanism, though – as with ergothioneine – this classification remains debated rather than settled.

What human evidence exists

Small human studies on PQQ have reported improvements in measures of cognitive function, including processing speed and memory performance, along with evidence from imaging studies that PQQ can increase ATP levels in neural tissue within 24 hours of dosing. These are genuinely interesting findings – but the human trial base is limited to a small number of small studies, not the large, independently replicated trial base that exists for well-studied ingredients like creatine or omega-3s.

How this compares to urolithin A

Both PQQ and urolithin A target mitochondrial health, but the maturity of their human evidence bases is meaningfully different. Urolithin A has multiple placebo-controlled randomized trials, including 4-month studies with functional outcomes like measured strength and endurance gains. PQQ’s human evidence is earlier-stage: fewer trials, smaller sample sizes, and shorter durations. If you are choosing between the two for mitochondrial support specifically, urolithin A currently has the stronger clinical trial case.

Dosing referenced in available research

Most of the available human research and product formulations use around 10-20mg/day of PQQ.

FAQ

Is PQQ better studied than urolithin A?
No – urolithin A currently has a larger and more mature base of randomized, placebo-controlled human trials with functional outcomes measured.

Is PQQ an officially recognized vitamin?
Its vitamin-like properties have been proposed and debated in the scientific literature, but it is not formally classified as an essential vitamin.

Can PQQ and urolithin A be taken together?
They target overlapping mitochondrial pathways through different mechanisms; there is no specific safety concern reported with combining them, but dedicated combination trials are limited.

Sources

• Perspective review, “Prolonging healthy aging: Longevity vitamins and proteins” (covers PQQ mechanism and evidence): PNAS

This article is for educational purposes and is not medical advice. Consult a healthcare provider before starting any new supplement.